STOCK TITAN

Inventiva (IVA) furnishes H1 2025 interim report and unaudited results

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Inventiva S.A. filed a Form 6-K as a foreign private issuer to provide investors with two key documents for the first half of 2025. The company furnished its Interim Financial Report for the six months ended June 30, 2025 as Exhibit 99.1 and a press release dated September 29, 2025 reporting unaudited first-half 2025 financial results and a corporate update as Exhibit 99.2. The filing is an information update and does not itself describe specific financial figures or major transactions.

Positive

  • None.

Negative

  • None.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of September 2025

Commission File Number: 001-39374

Inventiva S.A.

(Translation of registrant’s name into English)

50 rue de Dijon

21121 Daix France

+33 3 80 44 75 00

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F Form 40-F


Entry into Subscription Agreements

On September 29, 2025, the Registrant issued the Interim Financial Report for the Six Months Ended June 30, 2025 (the “Interim Financial Report”). A copy of the Interim Financial Report is attached to this Report as exhibit 99.1.

On September 29, 2025, the Registrant issued a press release (the “Press Release”) to report its unaudited 2025 first-half financial results and provide a corporate update. A copy of the Press Release is furnished as Exhibit 99.2 to this Report on Form 6-K.


EXHIBIT INDEX

Exhibit No.

    

Description

99.1

Interim Financial Report.

99.2

Press Release, dated September 29, 2025

101.INS XBRL

Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH XBRL

Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Inventiva S.A.

Date: September 29, 2025

By:

/s/ Frédéric Cren

Name

Frédéric Cren

Title:

Chief Executive Officer


FAQ

What did Inventiva S.A. (IVA) file in this Form 6-K?

Inventiva S.A. filed a Form 6-K to furnish its Interim Financial Report for the six months ended June 30, 2025 and a press release dated September 29, 2025 that reports unaudited first-half 2025 financial results and provides a corporate update.

Which financial period is covered by Inventiva S.A.’s interim report in this 6-K?

The interim financial information attached to this filing covers the six months ended June 30, 2025, as set out in the Interim Financial Report filed as Exhibit 99.1.

What information is included in Inventiva S.A.’s press release attached to the 6-K?

The press release furnished as Exhibit 99.2, dated September 29, 2025, reports unaudited first-half 2025 financial results and provides a corporate update on Inventiva S.A.

Does this Inventiva S.A. Form 6-K disclose detailed financial figures?

The summary of the Form 6-K indicates that detailed financial figures and related discussion are contained in the Interim Financial Report (Exhibit 99.1) and the press release (Exhibit 99.2), rather than in the body of the form itself.

What exhibits are attached to Inventiva S.A.’s September 2025 Form 6-K?

The filing includes Exhibit 99.1 (Interim Financial Report), Exhibit 99.2 (Press Release dated September 29, 2025), and several Inline XBRL documents labeled 101.INS and 101.SCH.

Inventiva S.A.

NASDAQ:IVA

IVA Rankings

IVA Latest News

IVA Latest SEC Filings

IVA Stock Data

1.38B
221.07M
Biotechnology
Healthcare
Link
France
Daix